235
Participants
Start Date
June 30, 2005
Primary Completion Date
October 31, 2007
Study Completion Date
October 31, 2007
Inhaled treprostinil
Doses are titrated to 9 breaths four times daily. Each breath produces an 18 mcg dose of inhaled treprostinil.
Placebo inhalation solution
Doses are titrated to 9 breaths four times daily.
Universite Libre de Bruxelles, Brussels
Universitatsklinikfur Innere Medizin II, Wein
Bethe Israel Medical Center, New York
Allegheny General Hospital, Pittsburgh
Johns Hopkins University, Baltimore
Duke University Medical Center, Durham
Rambam Medical Center, Haifa
Orlando Heart Center, Orlando
Kansas University Medical Center, Kansas City
UTSW Medical Center, Dallas
University of Colorado, Aurora
University of Arizona, Tucson
UCLA Medical Center, Torrance
UCSD Medical center, La Jolla
Hospital Antoine Beclere, Paris
University of Alabama, Birmingham
Tufts Medical Center, Boston
University of Michigan, Ann Arbor
Vanderbilt University Medical Center, Nashville
Medical University Graz, Graz
University Hospital Gasthuisburg, Leuven
Pulmonary Hypertension Unit, Dublin
The Pulmonary Institute, Jerusalem
The Pulmonary Institute, Petach Tikvah 49100
Instituto Malattie dell'Apparato Vascolare, Bologna
Scottish Pulmonary Vascular Unit, Glasgow GII 6NT
Royal Fee Hospital, London
Univesitatsklinikum Giessen und Marburg GmbH, Geißen
University of Barcelona, Barcelona
Papworth Hospital, Cambridge
Lead Sponsor
United Therapeutics
INDUSTRY